Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-04 to 2024-06-05
Current total value of award: $10326.11
Description: 4564800080!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML